Cristcot is a strategic pharmaceutical company focused in the space of gastroenterology to address large gaps in disease management that are overlooked by others and marked by a low competitive landscape. The first product is designed to halt acute flares in ulcerative colitis and has successfully completed Phase 3 clinical trials.